A similar defect in Aspergillus-mediated p40phox phosphorylation induction was also observed in neutrophils harvested from patients with lymphoma 3 days after initiation of ibrutinib treatment (Figure 5B) and in neutrophils from patients with XLA (Figure 5C). This evidence concerns the gene NCF4 and lymphoma.